Lumos Diagnostics Holdings Past Earnings Performance
Past criteria checks 0/6
Lumos Diagnostics Holdings's earnings have been declining at an average annual rate of -7.3%, while the Medical Equipment industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 0.9% per year.
Key information
-7.3%
Earnings growth rate
39.2%
EPS growth rate
| Medical Equipment Industry Growth | 5.8% |
| Revenue growth rate | 0.9% |
| Return on equity | -120.9% |
| Net Margin | -77.2% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Lumos Diagnostics Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 11 | -9 | 12 | 0 |
| 31 Mar 24 | 10 | -9 | 11 | 0 |
| 31 Dec 23 | 8 | -9 | 11 | 0 |
| 30 Sep 23 | 9 | -9 | 11 | 0 |
| 30 Jun 23 | 11 | -9 | 12 | 0 |
| 31 Mar 23 | 11 | -25 | 15 | 1 |
| 31 Dec 22 | 12 | -41 | 19 | 1 |
| 30 Sep 22 | 12 | -43 | 21 | 1 |
| 30 Jun 22 | 12 | -46 | 24 | 1 |
| 31 Mar 22 | 14 | -34 | 24 | 1 |
| 31 Dec 21 | 16 | -23 | 24 | 1 |
| 30 Sep 21 | 17 | -19 | 21 | 1 |
| 30 Jun 21 | 19 | -15 | 18 | 1 |
| 31 Mar 21 | 16 | -12 | 16 | 2 |
| 31 Dec 20 | 12 | -9 | 15 | 2 |
| 30 Sep 20 | 9 | -9 | 13 | 2 |
| 30 Jun 20 | 6 | -9 | 11 | 2 |
| 30 Jun 19 | 4 | -5 | 4 | 1 |
| 30 Jun 18 | 2 | -1 | 2 | 0 |
Quality Earnings: LDX is currently unprofitable.
Growing Profit Margin: LDX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: LDX is unprofitable, and losses have increased over the past 5 years at a rate of 7.3% per year.
Accelerating Growth: Unable to compare LDX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: LDX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (18.7%).
Return on Equity
High ROE: LDX has a negative Return on Equity (-120.86%), as it is currently unprofitable.